Cargando…
Should Preimplantation Genetic Testing (PGT) Systematically Be Proposed to BRCA Pathogenic Variant Carriers?
SIMPLE SUMMARY: Preimplantation genetic testing (PGT) has been developed to avoid the transmission of a critical hereditary disease, by selecting embryos for uterine transfer using a genetic analysis. BRCA mutated patients can undergo PGT and also be offered fertility preservation (FP) when diagnose...
Autores principales: | Laot, Lucie, Sonigo, Charlotte, Nobre, Julie, Benachi, Alexandra, Dervin, Traicie, El Moujahed, Lina, Mayeur, Anne, Stoppa-Lyonnet, Dominique, Steffann, Julie, Grynberg, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739906/ https://www.ncbi.nlm.nih.gov/pubmed/36497251 http://dx.doi.org/10.3390/cancers14235769 |
Ejemplares similares
-
Response to Ovarian Stimulation for Urgent Fertility Preservation before Gonadotoxic Treatment in BRCA-Pathogenic-Variant-Positive Breast Cancer Patients
por: El Moujahed, Lina, et al.
Publicado: (2023) -
BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis
por: Julian-Reynier, Claire, et al.
Publicado: (2012) -
Noninvasive Preimplantation Genetic Testing for Aneuploidy (niPGT-A): The first Brazilian baby
por: Franco Jr., José Gonçalves, et al.
Publicado: (2020) -
Noninvasive preimplantation genetic testing for aneuploidies (niPGT-A) and the principle of primum non nocere
por: Franco Jr, Jose G., et al.
Publicado: (2020) -
The biological effects and clinical implications of BRCA mutations: where do we go from here?
por: Stoppa-Lyonnet, Dominique
Publicado: (2016)